Evidence map›Paper›PMID 27198053›Full record

ArticleLeukemia2016

IKZF1 deletion is enriched in pediatric B-cell precursor acute lymphoblastic leukemia patients showing prednisolone resistance.

T Imamura, M Yano, D Asai, A Moriya-Saito, S-I Suenobu, D Hasegawa, T Deguchi, Y Hashii, H Kawasaki, H Hori and 4 more

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Leukemia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Biomedicines · 2024
    Review
  2. Review
  3. Reversal ofFrontiers in oncology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

T ImamuraDepartment of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
M YanoDepartment of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
D AsaiDepartment of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
A Moriya-SaitoClinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
S-I SuenobuJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
D HasegawaJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
T DeguchiJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
Y HashiiJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
H KawasakiJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
H HoriJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
K Yumura-YagiJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
J HaraJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
K HoribeJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
A SatoJapan Association of Childhood Leukemia Study Group (JACLS), Suita, Japan.
Kyoto Prefectural University of Medicine · JPMie University · JPNational Hospital Organization · JPKansai Medical University · JPKawamura Hospital · JPKobe Children's Hospital · JPMiyagi Children's Hospital · JPOita University · JPOsaka City General Hospital · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlucocorticoidsPrecursor Cell Lymphoblastic Leukemia-LymphomaB-LymphocytesChildHumansIkaros Transcription FactorPrednisoloneGlucocorticoidsIkaros Transcription FactorIKZF1 protein, humanPrednisolone

Identifiers

PMID27198053
OpenAlexW2397126460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.